Hypercalcaemia complicating immune reconstitution in an HIV-infected patient with disseminated tuberculosis.
An HIV positive man being treated for disseminated tuberculosis developed hypercalcaemia 17 days after starting highly active antiretroviral therapy (HAART). Hypercalcaemia resolved with stopping HAART and was thought to be due to immune reconstitution inflammatory syndrome.
Ferrand
R A
RA
Patrick Manson Unit, University College London Hospitals, London, UK.
Elgalib
A
A
Newsholme
W
W
Childerhouse
A
A
Edwards
S G
SG
Miller
R F
RF
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis; D018746:Systemic Inflammatory Response Syndrome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000995:Antitubercular Agents